Asthma Drug May Treat Rare Neurological Disorder
The asthma medication theophylline is a suitable drug for treating the rare neurological disorder ADCY5-related dyskinesia, according to a new study.
The asthma medication theophylline is a suitable drug for treating the rare neurological disorder ADCY5-related dyskinesia, according to a new study.
The asthma medication theophylline is a suitable drug for treating the rare neurological disorder ADCY5-related dyskinesia, according to a new study.
Read MoreA look at the latest aerosol delivery products from Aerogen, Alliance Tech Medical, Dynarex, Monaghan Medical, and Sunset Healthcare.
Read MoreExposure to thirdhand smoke is underestimated, according to a study of over 150 children that found 100% tested positive for low levels of cotinine—a biomarker of tobacco exposure.
Read MoreResults from the BATURA Phase IIIb trial found that albuterol–budesonide (AirSupra) demonstrated a 47% reduction in the risk of severe exacerbations in mild asthma compared with albuterol alone
Read MoreRefiloe Masekela, MD, PhD, a pediatric asthma specialist based in South Africa, will receive the American Thoracic Society’s 2025 World Lung Health Award.
Read MoreEnterovirus D68 (EV-D68) can cause severe respiratory illness in otherwise healthy children of all ages, and hospitalized children with non-asthma underlying conditions may be at higher risk for severe outcomes.
Read MorePeople who have struggled with asthma or allergies for years understand the psychological toll of these conditions.
Read MoreTwo Phase III trials in patients with uncontrolled asthma found Breztri Aerosphere met all primary endpoints, demonstrating a statistically significant and clinically meaningful improvement in lung function.
Read MoreChildren residing in a state experiencing high Medicaid enrollment loss experienced a greater decrease in the number of days with active medication prescriptions.
Read MoreStudy suggests the 2024 withdrawal of the asthma medication Flovent was linked to increases in children discontinuing inhaled steroid therapy.
Read MoreSmoke from June 2023 Canadian wildfires cooled New York City by about 3°C and trapped pollutants that severely degraded air quality and spurred emergency visits for asthma and respiratory issues.
Read MoreRepeated antibiotic use before age 2 is associated with a higher risk for asthma, food allergies and hay fever later in life.
Read MoreAnalysis of a school-based asthma therapy program in Ohio found significant health and behavioral improvements for students while saving thousands of dollars in medical costs via lower emergency care and hospitalizations.
Read MoreChildren exposed to higher levels of ozone in their first two years of life were significantly more likely to be diagnosed with asthma or wheezing at ages 4-6.
Read MoreResearchers estimate about 25 million young people ages 5 to 25 are now living with a chronic condition or functional limitation, including asthma.
Read MoreNew research indicates that postnatal antibiotic exposure, not associated with additional respiratory infections, is associated with childhood asthma.
Read MoreTwo potential asthma treatments that target key molecules to prevent immune cells from triggering asthma attacks, offering the possibility of long-term relief.
Read MoreUnderstanding how to help asthma patients perform self-monitoring and self-management in the home is the key to provide quality, effective support.
Read MoreResearchers are investigating prenatal exposure to nanoplastics, which can affect the immune system and potentially influence development of asthma and allergies.
Read MoreResearchers have identified a new population of immune cells in the airways that contribute to inflammation in severe asthma, offering new insights for potential treatments.
Read MoreAustralia’s Therapeutic Goods Administration recently issued a safety alert requiring extra warnings to be included with the asthma and hay fever drug montelukast.
Read MoreScientists at Rutgers Health have discovered that a simple blood test could diagnose asthma and determine its severity.
Read MoreA $3.4 million NIH grant will help expand and improve the Stock Inhaler for Schools program, which provides albuterol inhalers to students.
Read MoreResearchers at the University of Pittsburgh have developed a nasal swab test to diagnose specific asthma subtypes in children.
Read More